With tens of millions of people facing life with type 2 diabetes and many millions more at risk of the disease, scientists are scrambling to
Optos plc (LSE: OPTS), a leading medical retinal imaging company, has announced the results of a clinical validation study comparing Optos ultra-widefield imaging to Early
A small Chinese study has reported that 15 of 28 young type 1 patients, aged 14 to 30 years, who underwent an experimental adult stem
Metformin is the aspirin of the diabetes world, an almost-wonder drug that proves itself again and again the longer it’s around. This time, a new
A successful experiment on mice with type 1 diabetes, which involved “reprogramming” their immune systems to stop attacks on pancreatic beta cells, may point the
To address the underlying autoimmune process that is central to type 1 diabetes, JDRF in the USA and Novo Nordisk are partnering to discover and
As reported by Diabetes Health Staff in April 2012, bariatric surgery, not medications, may be the key to producing dramatic drops in weight and even
Health professionals from surgeons and psychiatrists to paediatricians and GPs are joining forces under the umbrella of the Academy of Royal Medical Colleges (AoMRC) to
Her Royal Highness The Duchess of Cornwall has chosen to become JDRF’s President. Her Royal Highness made the decision to support us following her visit
The latest issue of the magazine is out. We hear from four graduates of the DAFNE education courses for people with T1 diabetes. Plus, news,
